img

Global Etoricoxib Market Segment Research Report 2024


Published on: 2024-01-04 | No of Pages : 420 | Industry : Pharma & Healthcare Research Center

Publisher : MRX | Format : PDF

Global Etoricoxib Market Segment Research Report 2024

Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch)released the 《(Post-pandemic Era)-Global Etoricoxib Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Etoricoxib industry at home and abroad, estimate the overall market scale of the Etoricoxib industry and the market share of major countries, Etoricoxib industry, and study and judge the downstream market demand of Etoricoxib through systematic research, Analyze the competition pattern of Etoricoxib, so as to help solve the pain points of various stakeholders in Etoricoxib industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Etoricoxib Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Etoricoxib Market?
Morepen Laboratories
Merck & Co
Frosst Iberica SA
Metrochem API
Atom Pharma
Hema Pharmaceuticals
Beijing Tide Pharmaceutical
Qilu Pharmaceutical
Shanghai Shyndec Pharmaceutical
Easton Biopharmaceuticals
Major Type of Etoricoxib Covered in XYZResearch report
30 mg
60 mg
90 mg
120 mg
Application Segments Covered in XYZResearch Market
Hospital
Pharmacy
Others

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global Etoricoxib Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Etoricoxib Market by Value
2.2.1 Global Etoricoxib Revenue by Type
2.2.2 Global Etoricoxib Market by Value (%)
2.3 Global Etoricoxib Market by Production
2.3.1 Global Etoricoxib Production by Type
2.3.2 Global Etoricoxib Market by Production (%)

3. The Major Driver of Etoricoxib Industry
3.1 Historical & Forecast Global Etoricoxib Demand
3.2 Largest Application for Etoricoxib (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Etoricoxib Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Etoricoxib Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Etoricoxib Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Etoricoxib Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Etoricoxib Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Etoricoxib Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Etoricoxib Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Etoricoxib Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Etoricoxib Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Etoricoxib Average Price Trend
12.1 Market Price for Each Type of Etoricoxib in US (2018-2022)
12.2 Market Price for Each Type of Etoricoxib in Europe (2018-2022)
12.3 Market Price for Each Type of Etoricoxib in China (2018-2022)
12.4 Market Price for Each Type of Etoricoxib in Japan (2018-2022)
12.5 Market Price for Each Type of Etoricoxib in India (2018-2022)
12.6 Market Price for Each Type of Etoricoxib in Korea (2018-2022)
12.7 Market Price for Each Type of Etoricoxib in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Etoricoxib Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Etoricoxib

14. Etoricoxib Competitive Landscape
14.1 Morepen Laboratories
14.1.1 Morepen Laboratories Company Profiles
14.1.2 Morepen Laboratories Product Introduction
14.1.3 Morepen Laboratories Etoricoxib Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Merck & Co
14.2.1 Merck & Co Company Profiles
14.2.2 Merck & Co Product Introduction
14.2.3 Merck & Co Etoricoxib Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Frosst Iberica SA
14.3.1 Frosst Iberica SA Company Profiles
14.3.2 Frosst Iberica SA Product Introduction
14.3.3 Frosst Iberica SA Etoricoxib Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Metrochem API
14.4.1 Metrochem API Company Profiles
14.4.2 Metrochem API Product Introduction
14.4.3 Metrochem API Etoricoxib Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Atom Pharma
14.5.1 Atom Pharma Company Profiles
14.5.2 Atom Pharma Product Introduction
14.5.3 Atom Pharma Etoricoxib Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Hema Pharmaceuticals
14.6.1 Hema Pharmaceuticals Company Profiles
14.6.2 Hema Pharmaceuticals Product Introduction
14.6.3 Hema Pharmaceuticals Etoricoxib Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Beijing Tide Pharmaceutical
14.7.1 Beijing Tide Pharmaceutical Company Profiles
14.7.2 Beijing Tide Pharmaceutical Product Introduction
14.7.3 Beijing Tide Pharmaceutical Etoricoxib Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Qilu Pharmaceutical
14.8.1 Qilu Pharmaceutical Company Profiles
14.8.2 Qilu Pharmaceutical Product Introduction
14.8.3 Qilu Pharmaceutical Etoricoxib Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Shanghai Shyndec Pharmaceutical
14.9.1 Shanghai Shyndec Pharmaceutical Company Profiles
14.9.2 Shanghai Shyndec Pharmaceutical Product Introduction
14.9.3 Shanghai Shyndec Pharmaceutical Etoricoxib Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Easton Biopharmaceuticals
14.10.1 Easton Biopharmaceuticals Company Profiles
14.10.2 Easton Biopharmaceuticals Product Introduction
14.10.3 Easton Biopharmaceuticals Etoricoxib Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source


List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Etoricoxib Industry (Volume)
Figure 2. Etoricoxib Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Etoricoxib Revenue in 2022
Figure 5. US Etoricoxib Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Etoricoxib Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Etoricoxib Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Etoricoxib Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Etoricoxib Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Etoricoxib Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Etoricoxib Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Etoricoxib Revenue, by Type (Million USD) (2018-2028)
Table 4. Etoricoxib Production, by Type (K Unit) (2018-2028)
Table 5. Etoricoxib Demand (K Unit) by Application (2018-2028)
Table 6. Etoricoxib Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Etoricoxib Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Etoricoxib Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Etoricoxib Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Etoricoxib Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Etoricoxib Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Etoricoxib Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Etoricoxib Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Etoricoxib Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Etoricoxib in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Etoricoxib in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Etoricoxib in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Etoricoxib in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Etoricoxib in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Etoricoxib in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Etoricoxib in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Morepen Laboratories Profiles
Table 61. Morepen Laboratories Etoricoxib Product Introduction
Table 62. Morepen Laboratories Etoricoxib Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Morepen Laboratories Strategic initiatives
Table 64. Merck & Co Profiles
Table 65. Merck & Co Etoricoxib Product Introduction
Table 66. Merck & Co Etoricoxib Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Merck & Co Strategic initiatives
Table 68. Frosst Iberica SA Profiles
Table 69. Frosst Iberica SA Etoricoxib Product Introduction
Table 70. Frosst Iberica SA Etoricoxib Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Frosst Iberica SA Strategic initiatives
Table 72. Metrochem API Profiles
Table 73. Metrochem API Etoricoxib Product Introduction
Table 74. Metrochem API Etoricoxib Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Metrochem API Strategic initiatives
Table 76. Atom Pharma Profiles
Table 77. Atom Pharma Etoricoxib Product Introduction
Table 78. Atom Pharma Etoricoxib Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Atom Pharma Strategic initiatives
Table 80. Hema Pharmaceuticals Profiles
Table 81. Hema Pharmaceuticals Etoricoxib Product Introduction
Table 82. Hema Pharmaceuticals Etoricoxib Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Hema Pharmaceuticals Strategic initiatives
Table 84. Beijing Tide Pharmaceutical Profiles
Table 85. Beijing Tide Pharmaceutical Etoricoxib Product Introduction
Table 86. Beijing Tide Pharmaceutical Etoricoxib Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Beijing Tide Pharmaceutical Strategic initiatives
Table 88. Qilu Pharmaceutical Profiles
Table 89. Qilu Pharmaceutical Etoricoxib Product Introduction
Table 90. Qilu Pharmaceutical Etoricoxib Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Qilu Pharmaceutical Strategic initiatives
Table 92. Shanghai Shyndec Pharmaceutical Profiles
Table 93. Shanghai Shyndec Pharmaceutical Etoricoxib Product Introduction
Table 94. Shanghai Shyndec Pharmaceutical Etoricoxib Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Shanghai Shyndec Pharmaceutical Strategic initiatives
Table 97. Easton Biopharmaceuticals Profiles
Table 98. Easton Biopharmaceuticals Etoricoxib Product Introduction
Table 99. Easton Biopharmaceuticals Etoricoxib Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Easton Biopharmaceuticals Strategic initiatives